These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34085414)

  • 41. Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial.
    Kayo AH; Peccin MS; Sanches CM; Trevisani VF
    Rheumatol Int; 2012 Aug; 32(8):2285-92. PubMed ID: 21594719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial.
    Kashikar-Zuck S; Ting TV; Arnold LM; Bean J; Powers SW; Graham TB; Passo MH; Schikler KN; Hashkes PJ; Spalding S; Lynch-Jordan AM; Banez G; Richards MM; Lovell DJ
    Arthritis Rheum; 2012 Jan; 64(1):297-305. PubMed ID: 22108765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Social variables for replication of studies using mean scores of social support, self-care, and fibromyalgia knowledge: a cross-sectional study.
    Pontes-Silva A; Nunes I; De Miguel-Rubio A; de Souza MC; DeSantana JM; Avila MA
    Rheumatol Int; 2023 Sep; 43(9):1705-1721. PubMed ID: 37335339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased frequency of fibromyalgia among patients with chronic pain presenting to internal medicine clinics of a tertiary care hospital: A cross sectional study.
    Javed S; Zaid M; Imran S; Hai A; Patel MJ
    J Pak Med Assoc; 2021 Dec; 71(12):2740-2747. PubMed ID: 35150531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychological therapies for the management of chronic and recurrent pain in children and adolescents.
    Fisher E; Law E; Dudeney J; Palermo TM; Stewart G; Eccleston C
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD003968. PubMed ID: 30270423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases.
    Raffaeli W; Malafoglia V; Bonci A; Tenti M; Ilari S; Gremigni P; Iannuccelli C; Gioia C; Di Franco M; Mollace V; Vitiello L; Tomino C; Muscoli C
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of the American College of Rheumatology 2016 criteria for fibromyalgia in a referral care setting.
    Ahmed S; Aggarwal A; Lawrence A
    Rheumatol Int; 2019 Aug; 39(8):1397-1403. PubMed ID: 31101966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pilot study of health and wellness coaching for fibromyalgia.
    Hackshaw KV; Plans-Pujolras M; Rodriguez-Saona LE; Moore MA; Jackson EK; Sforzo GA; Buffington CA
    BMC Musculoskelet Disord; 2016 Nov; 17(1):457. PubMed ID: 27821160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of fibromyalgia on health status according to the types, demographic background and pain index.
    Ghavidel-Parsa B; Bidari A; Maafi AA; Hassankhani A; Hajiabbasi A; Montazeri A; Sanaei O; Ghalehbaghi B
    Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S134-9. PubMed ID: 27157398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is a new perspective for definition and diagnostic criteria of fibromyalgia in early stage cancer patients necessary?
    Tanriverdi O
    Med Hypotheses; 2014 Apr; 82(4):433-6. PubMed ID: 24548756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States.
    Schaefer C; Mann R; Masters ET; Cappelleri JC; Daniel SR; Zlateva G; McElroy HJ; Chandran AB; Adams EH; Assaf AR; McNett M; Mease P; Silverman S; Staud R
    Pain Pract; 2016 Jun; 16(5):565-79. PubMed ID: 25980433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status.
    Salaffi F; Di Carlo M; Farah S; Atzeni F; Buskila D; Ablin JN; Häuser W; Sarzi-Puttini P
    Rheumatology (Oxford); 2020 Oct; 59(10):3042-3049. PubMed ID: 32206792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey.
    Boehnke KF; Gagnier JJ; Matallana L; Williams DA
    J Pain; 2021 May; 22(5):556-566. PubMed ID: 33400996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and validation of a predictive model for determining the risk of developing fibromyalgia.
    Benachi Sandoval N; Fernández Solà J; Guaita Mateo A; Navarrete Durán MP; Meneses Urrea LA; Torres Belmonte S; Mañes López E; López Poyato M
    Clin Exp Rheumatol; 2023 Jun; 41(6):1238-1247. PubMed ID: 36622095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and diagnostic tests for fibromyalgia (syndrome).
    Häuser W; Wolfe F
    Reumatismo; 2012 Sep; 64(4):194-205. PubMed ID: 23024964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of patients' understanding of fibromyalgia: Results from an online qualitative survey.
    Black LL; Black WR; Chadwick A; Christofferson JL; Katz H; Kragenbrink M
    Patient Educ Couns; 2024 May; 122():108156. PubMed ID: 38242011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hierarchical Clustering Applied to Chronic Pain Drawings Identifies Undiagnosed Fibromyalgia: Implications for Busy Clinical Practice.
    Alter BJ; Moses M; DeSensi R; O'Connell B; Bernstein C; McDermott S; Jeong JH; Wasan AD
    J Pain; 2024 Jul; 25(7):104489. PubMed ID: 38354967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A mind-body technique for symptoms related to fibromyalgia and chronic fatigue.
    Toussaint LL; Whipple MO; Abboud LL; Vincent A; Wahner-Roedler DL
    Explore (NY); 2012; 8(2):92-8. PubMed ID: 22385563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of predictors of the impact of fibromyalgia on health-related quality of life 12 months after the end of an interdisciplinary treatment.
    Martín J; Torre F; Aguirre U; Padierna A; Matellanes B; Quintana JM
    J Affect Disord; 2017 Jan; 208():76-81. PubMed ID: 27750063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving the primary care physicians' decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening tool.
    Baron R; Perrot S; Guillemin I; Alegre C; Dias-Barbosa C; Choy E; Gilet H; Cruccu G; Desmeules J; Margaux J; Richards S; Serra E; Spaeth M; Arnould B
    Health Qual Life Outcomes; 2014 Oct; 12():128. PubMed ID: 25341959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.